Furthermore, instances of FRAT1 overexpression have been documented in various cancers, including ovarian cancer, gastric cancer, esophageal squamous cell carcinoma, and non-small cell lung cancer [55,56,57,58]. This evidence concerns the gene FRAT1 and non-small cell lung carcinoma.